PURE Bioscience (OTCMKTS:PURE) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

PURE Bioscience (OTCMKTS:PURE)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.09. PURE Bioscience shares last traded at $0.0823, with a volume of 38,280 shares trading hands.

PURE Bioscience Price Performance

The company has a market capitalization of $9.21 million, a P/E ratio of -2.74 and a beta of 0.26. The company has a fifty day moving average price of $0.07 and a 200 day moving average price of $0.06.

PURE Bioscience (OTCMKTS:PURE) last posted its earnings results on Monday, March 16th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.44 million during the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.